The State of Play in Biotech and the Decisions Shaping the Industry
Aug 12, 2026 - 60:58
Radio and PodcastLive Radio & Podcasts
Business
How ElevateBio Is Betting On Every Gene Editing Modality At Once
On the heels of Eli Lilly recently committing $3.3bn across two recombinase-focused deals, the question for the field is which gene editing modality, and which delivery system, will get large genetic payloads safely into...
About This Episode
How ElevateBio Is Betting On Every Gene Editing Modality At Once is an episode from Pharma Intelligence Podcasts. On the heels of Eli Lilly recently committing $3.3bn across two recombinase-focused deals, the question for the field is which...
Podcast
This episode belongs to Pharma Intelligence Podcasts.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Jul 21, 2026, 26:02 long, audio available.
Related Episodes
Continue listening to more episodes from Pharma Intelligence Podcasts.
Strategic Intent: First-in-class, two markets: Annexon’s GBS and GA Strategies
Aug 11, 2026 - 33:35
Drug Fix: Regulatory Nationalism And US FDA’s IND Reforms
Aug 7, 2026 - 24:29
Proof of Concept - AI in Drug Discovery
Aug 6, 2026 - 46:43
Podcast: China's Evolving Role in Global Clinical Development
Aug 4, 2026 - 17:39
